Status | Study |
NOT_YET_RECRUITING |
Study Name: Tulmimetostat (CPI-0209) in Patients With Mycosis Fungoides and S�zary Syndrome Condition: Mycosis Fungoides Date: 2023-07-05 Interventions: Patients should take CPI-0209 at approximately the same time every morning in a fasted state (no food for 2 hours prior and 1 hour following CPI-0209 |
RECRUITING |
Study Name: Histopathological Changes in Mycosis Fungoides Condition: Date: 2023-06-06 Interventions: biopsy for histopathological examination |
RECRUITING |
Study Name: Pembrolizumab Administered Via the Sofusa� DoseConnect� in Patients With Relapsed/Refractory Cutaneous T-cell Lymphoma. Condition: Mycosis Fungoides Date: 2019-10-04 Interventions: pembrolizumab will be administered intralymphatically using the Sofusa� DoseConnect� device |
Recruiting |
Study Name: Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS) Condition: Mycosis Fungoides Sezary Syndrome Date: 2016-10-26 Interventions: Drug: resminostat Other Name: |
Not yet recruiting |
Study Name: Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides Condition: Mycosis Fungoides Date: 2016-10-18 Interventions: Biological: A-dmDT390-bisFv(UCHT1) |
Not yet recruiting |
Study Name: Low Dose Total Skin Electron Beam Treatment (TSEBT) Followed by Maintenance Valchlor for Patients With Mycosis Fungoides Condition: Mycosis Fungoides Cutaneous T-cell Lymphoma Date: 2016-08-24 Interventions: Radiation: Total skin electron beam therapy (TSEBT) |
Recruiting |
Study Name: ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome Condition: Mycosis Fungoides Non-Hodgkin's Lymphoma Date: 2016-07-25 |
Recruiting |
Study Name: TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome Condition: Mycosis Fungoides Sézary Syndrome Date: 2016-06-30 Interventions: Radiation: TSEB Therapy TSEB i |
Recruiting |
Study Name: Naloxone Hydrochloride Study for Relief of Pruritus in Patients With Mycosis Fungoides (MF) Form of CTCL Condition: Mycosis Fungoides Lymphoma, T-Cell, Cutaneous Date: 2016-06-15 Interventions: Drug: Naloxone Hydrochloride Lotion, 0.5% |
Recruiting |
Study Name: Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides Condition: Recurrent Mycosis Fungoides Refractory My Date: 2016-02-29 Interventions: Other: Quality-of-Life Assessment |